“BCR-ABL Quantitative Test | Accurate Monitoring for Leukemia Detection” has been added to your cart.
View cart -
د.إ3,250.00
The BCR/ABL – Quantitative test is a highly sensitive molecular diagnostic assay used to detect and quantify the BCR-ABL fusion gene, a key biomarker in chronic myeloid leukemia (CML) and some acute lymphoblastic leukemias (ALL). Utilizing real-time PCR technology, it provides precise measurement of BCR-ABL transcript levels, enabling accurate disease monitoring and treatment response assessment.
Sample Type : Whole Blood
Methodology : Real time PCR
TAT : 8-10 Days
-
د.إ650.00
Includes the following parameters:
- Alpha-Fetoprotein (AFP)
- CA 19.9, Serum (Pancreatic Cancer Marker)
- Carcinoembryonic Antigen (CEA), Serum
- Prostate-Specific Antigen (PSA), Total Serum
- Prostate-Specific Antigen (PSA), Free Serum
- Human Chorionic Gonadotropin (HCG)
-
د.إ13,000.00
Liquid HALLMARK is a comprehensive liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from a simple blood draw to detect and monitor cancer.
Sample Type : Serum
Methodology : Ultra-deep sequencing using Lucence’s proprietary AmpliMARK™ technology
TAT : 8-10 Days
